UAE Chronic Cough Therapeutics Market Analysis

UAE Chronic Cough Therapeutics Market Analysis


$ 3999

UAE Chronic Cough Therapeutics Market was valued at $32 Mn in 2022 and is estimated to reach $63 Mn in 2030, exhibiting a CAGR of 9.1% during the forecast period. The main driver behind the growth of the chronic cough therapeutics market is the extensive prevalence of chronic respiratory infections, often signaled by the occurrence of chronic cough. Presently, key participants in this market consist of GlaxoSmithKline (GSK), Pfizer, McNeil Consumer Healthcare (Johnson & Johnson), Procter & Gamble (P&G), Reckitt Benckiser Group, Perrigo Company, Medtech Products Inc., Bionpharma Inc., A. Vogel Canada Inc., and Jamieson Laboratories.

ID: IN10ESPH306 CATEGORY: Pharmaceuticals GEOGRAPHY: UAE AUTHOR: Medha Sansanwal

Buy Now

UAE Chronic Cough Therapeutics Market Executive Summary

UAE Chronic Cough Therapeutics Market was valued at $32 Mn in 2022 and is estimated to reach $63 Mn in 2030, exhibiting a CAGR of 9.1% during the forecast period.

Chronic cough is a persistent cough that lasts for an extended period, typically lasting more than eight weeks. Unlike acute coughs, which are often associated with infections or other short-term conditions, chronic cough can be a symptom of an underlying and more persistent health issue. Common causes of chronic cough include respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), gastroesophageal reflux disease (GERD), postnasal drip, and certain medications. Identifying and addressing the underlying cause of chronic cough through a thorough medical evaluation is important, as treating the root issue is crucial for effective management. Chronic cough can significantly impact an individual's quality of life and may require a multidisciplinary approach involving healthcare professionals such as pulmonologists, gastroenterologists, or ear, nose, and throat (ENT) specialists for comprehensive care.

The prevalence of chronic cough and related respiratory conditions in the United Arab Emirates (UAE) is a significant public health concern. The prevalence of asthma was 12.3%, chronic bronchitis was 1.8%, and emphysema was 0.5%. Additionally, 34.8% of the adolescents reported a dry nocturnal cough in the past year. A prevalence of chronic bronchitis of 0.6% is seen in the UAE. Furthermore, the prevalence of chronic obstructive pulmonary disease (COPD) in the UAE was found to range from 3.7% to 5.3% in the Middle East and North Africa region.

Pfizer has unveiled plans for a novel over-the-counter (OTC) cough syrup formulation, merging dextromethorphan and guaifenesin. This formulation is designed to address both cough and mucus production. Additionally, Boehringer Ingelheim has entered into a strategic partnership with a digital health company to create a mobile application tailored for managing chronic cough. The app aims to offer features such as symptom tracking, educational resources, and potential connections to healthcare professionals, enhancing the overall management of chronic cough for users.

UAE Cough Therapeutics Market Report 2022 to 2030

Market Dynamics

Market Growth Drivers

Aging Population: The expansion of the aging population holds significant importance in the UAE, with estimates projecting a rise to 16% by 2050, signifying a noteworthy alteration in the age demographics. This growing aging population in the UAE plays a pivotal role in driving the expansion of the chronic cough therapeutics market. As individuals age, there is an elevated susceptibility to respiratory conditions, contributing to an increased prevalence of chronic cough within this demographic.

Changing Lifestyles and Environmental Factors: Lifestyle changes and environmental factors, such as air pollution and exposure to allergens, can contribute to the increase in chronic cough cases. The market responds to these challenges by providing therapeutics to address the symptoms and underlying causes.

Prevalence of Chronic Respiratory Conditions: The high prevalence of chronic respiratory conditions within the population contributes significantly to the demand for chronic cough therapeutics. As chronic cough is often associated with respiratory issues, the market experiences growth due to the need for effective treatment options.

Market Restraints

Cultural and Social Stigmas: Hesitancy in seeking medical attention may arise from cultural and social stigmas linked to respiratory conditions. Societal perceptions may discourage individuals from openly discussing or addressing chronic coughs, resulting in a tendency for underreporting and undertreatment of the condition.

Limited Awareness and Education: Lack of awareness and education about chronic cough and available treatment options among both healthcare professionals and the general population can hinder the market. This may result in delayed diagnosis and inadequate management of the condition.

Healthcare Infrastructure Challenges: Challenges in the healthcare infrastructure, including limited access to specialized care and diagnostic facilities, can impede the effective diagnosis and treatment of chronic cough. Insufficient healthcare resources may hinder the market's growth potential.

Healthcare Policies and Regulatory Landscape

In the United Arab Emirates (UAE), the oversight and regulation of treatment drugs are primarily coordinated by key entities such as the Ministry of Health and Prevention (MOHAP), Health Authority Abu Dhabi (HAAD), Dubai Health Authority (DHA), Emirates Health Services Establishment (EHSE), and the Pharmaceutical Services Department (PSD). MOHAP, serving as a central regulatory authority, holds a crucial role in shaping and enforcing healthcare policies to guarantee the safety, effectiveness, and quality of pharmaceuticals. Additionally, regional health authorities like HAAD and DHA manage healthcare services, including drug regulations, within their respective emirates. EHSE contributes to federal-level regulations, while PSD, operating under MOHAP, concentrates on pharmaceutical-related activities. The Centralized Procurement Office (CPO) is actively engaged in acquiring pharmaceuticals for public healthcare facilities, ensuring compliance with regulatory standards.

Competitive Landscape

Key Players

  • GlaxoSmithKline (GSK)
  • Pfizer
  • McNeil Consumer Healthcare (Johnson & Johnson)
  • Procter & Gamble (P&G)
  • Reckitt Benckiser Group
  • Perrigo Company
  • Medtech Products Inc.
  • Bionpharma Inc.
  • A. Vogel Canada Inc.
  • Jamieson Laboratories

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

UAE Chronic Cough Therapeutics Market Segmentation

By Drug Class

  • Antihistamines
  • Corticosteroids
  • Decongestants
  • Combination Drug
  • Antibiotics
  • Acid Blockers
  • Others

By Route of Administration

  • Oral
  • Inhalational
  • Injectable
  • Others

By End-Users

  • Hospitals
  • Homecare
  • Speciality Centres
  • Others

By Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 06 June 2024
Updated by: Dhruv Joshi

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up